Pneumonia News and Research

Latest Pneumonia News and Research

Discovery could pave the way for new approaches to treating chronic respiratory diseases

An international research team has discovered a new cell state in embryonic airway development that has been overlooked until now.

11 Apr 2023

HIV diagnoses increases more than three-fold after implementing targeted testing in EDs

Targeted testing for HIV in emergency departments has great potential for increasing diagnoses, this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Copenhagen, Denmark, (15-18 April), will hear.

10 Apr 2023

Impact of maternal COVID-19 on neonatal brain development

Researchers described two coronavirus disease 2019 (COVID-19) -infected neonate cases.

10 Apr 2023

The distribution and prevalence of SARS-CoV-2 in the Huanan seafood market

Researchers surveyed SARS-CoV-2 at the Huanan seafood market (HSM).

10 Apr 2023

Study suggests potential therapeutic targets for COVID-19-related neurological pathologies

In a recent study published in the journal Molecular & Cellular Proteomics, researchers analyzed the proteins in cerebrospinal fluid (CSF) samples obtained from African green monkeys and rhesus macaques infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 to understand the neurological manifestations of coronavirus disease 2019 (COVID-19).

9 Apr 2023

Nasal SARS-CoV-2 vaccine outperforms existing vaccines in preclinical trial

Researchers assess the role of the live-attenuated vaccine sCPD9 in inducing systemic and mucosal immunity against SARS-CoV-2 variants.

6 Apr 2023

SFU researchers study pathogen genes to develop new drugs against bacterial infections

Researchers at Simon Fraser University are studying the genes of superbugs to aid the development of new and effective treatments for drug-resistant bacterial infections.

5 Apr 2023

New method for lower respiratory tract infection diagnosis in critically ill children

Lower respiratory tract infection (LRTI), which includes conditions such as pneumonia, has long been the leading cause of death from communicable agents and a leading cause of death in children worldwide.

5 Apr 2023

Study assesses the cellular and molecular immunopathology of post-COVID lung disease

Researchers assessed the cellular and molecular level immunopathology of PCLD.

4 Apr 2023

Could mink serve as an immediate host for Influenza A transmission?

A recent study discussed influenza A virus infections in minks, emphasizing their contribution/role as an intermediate host.

3 Apr 2023

Study offers a novel therapeutic option to combat antibiotic-resistant pneumonia

Increases in multidrug-resistance in the bacteria Streptococcus pneumoniae have made it the fourth-leading cause of death associated with antibiotic resistance.

29 Mar 2023

Study finds unusual peak in RSV hospitalizations in late 2021

The COVID-19 pandemic posed an immense challenge on the health care industry in 2020 and 2021. While hospitals were inundated with COVID-19 cases, other illnesses such as respiratory syncytial virus (RSV) saw a decrease in hospital visits, particularly in the fourth quarter of 2020 and the first quarter of 2021.

28 Mar 2023

Case report on Nocardia pseudobrasiliensis and SARS-CoV-2 concomitant infection

In a recent case report published in the U.S. Centers for Disease Control and Prevention’s (CDC) journal Emerging Infectious Diseases, researchers reported a case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Nocardia pseudobrasiliensis concomitant infection.

27 Mar 2023

Pneumolysin toxin holds promise for developing therapies against Streptococcus pneumoniae

In a recent study published in the journal PLoS ONE, researchers in Spain performed a systematic review of pneumolysin (PLY) toxin as a molecular target to develop novel therapeutics against Streptococcus pneumoniae.

27 Mar 2023

Tulane receives up to $16 million to move nasal pneumonia vaccine from the lab to clinical trials

The National Institute of Allergy and Infectious Diseases awarded an up to $16 million contract to Tulane University to bring to phase one clinical trial a nasal spray vaccine university researchers invented to thwart antibiotic-resistant Klebsiella pneumoniae, a leading cause of pneumonia.

24 Mar 2023

Candida auris infection without epidemiologic links to a prior outbreak

The Centers for Disease Control and Prevention (CDC) has classified Candida auris (C. auris) as an urgent public threat due to its role in elevating mortality, its ability to persist in hospital environments, and the high possibility of developing pan-drug resistance.

23 Mar 2023

Pneumonia News and Research

Latest Pneumonia News and Research

Discovery could pave the way for new approaches to treating chronic respiratory diseases

HIV diagnoses increases more than three-fold after implementing targeted testing in EDs

Impact of maternal COVID-19 on neonatal brain development

The distribution and prevalence of SARS-CoV-2 in the Huanan seafood market

Study suggests potential therapeutic targets for COVID-19-related neurological pathologies

Nasal SARS-CoV-2 vaccine outperforms existing vaccines in preclinical trial

SFU researchers study pathogen genes to develop new drugs against bacterial infections

New method for lower respiratory tract infection diagnosis in critically ill children

Study assesses the cellular and molecular immunopathology of post-COVID lung disease

Could mink serve as an immediate host for Influenza A transmission?

Study offers a novel therapeutic option to combat antibiotic-resistant pneumonia

Study finds unusual peak in RSV hospitalizations in late 2021

Case report on Nocardia pseudobrasiliensis and SARS-CoV-2 concomitant infection

Pneumolysin toxin holds promise for developing therapies against Streptococcus pneumoniae

Tulane receives up to $16 million to move nasal pneumonia vaccine from the lab to clinical trials

Candida auris infection without epidemiologic links to a prior outbreak

Being ‘socially frail’ comes with health risks for older adults

People with epilepsy have an increased risk of early death based on various factors

Study suggests a novel strategy to combat multidrug-resistant S. pneumoniae infections

A high-throughput CAMP assay for the evaluation of the vitamin D-dependent antimicrobial response

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Pneumonia News and Research

Latest Pneumonia News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in